Induction FLOT With CROSS CRT for Esophageal Cancer

NCT04028167 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma Esophagus
Adenocarcinoma of the Gastroesophageal Junction

Interventions

DRUG: Sequential FLOT followed by chemoradiation

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]